Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Daktari Diagnostics brings in $10mm

Executive Summary

In what appears to be its third financing, Daktari Diagnostics Inc. (developed a CD4 cell counting system) raised $10mm in a round of equity and debt from lead investor Merck Global Health Innovation Fund and returning shareholders Norwich Ventures and Partners Innovation Fund. According to the Form D filing, a total of 41 investors participated. The money will be used to finish developing and launch its initial products for HIV monitoring.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies